122 related articles for article (PubMed ID: 18328193)
41. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
42. [Establishment of AFP promoter operated murine IL-1beta recombinant vector and its expression in H22 cells].
Li QC; Liang SJ; Wang XJ; Liu YY; Wang HQ; Zhang SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):603-5. PubMed ID: 19737477
[TBL] [Abstract][Full Text] [Related]
43. [Anti-hepatocarcinoma effect of recombinant adenovirus carrying melittin gene].
Ling CQ; Li B; Zhang C; Gu W; Li SX; Huang XQ; Zhang YN
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):741-4. PubMed ID: 15619342
[TBL] [Abstract][Full Text] [Related]
44. Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.
Zhang Q; Yuan XF; Lu Y; Li ZZ; Bao SQ; Zhang XL; Yang YY; Fan DM; Zhang YZ; Wu CX; Guo HX; Zhang YJ; Ye Z; Xiong DS
Int J Cancer; 2017 Oct; 141(7):1445-1457. PubMed ID: 28643325
[TBL] [Abstract][Full Text] [Related]
45. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
46. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
47. A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.
Hallenbeck PL; Chang YN; Hay C; Golightly D; Stewart D; Lin J; Phipps S; Chiang YL
Hum Gene Ther; 1999 Jul; 10(10):1721-33. PubMed ID: 10428217
[TBL] [Abstract][Full Text] [Related]
48. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
49. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
[TBL] [Abstract][Full Text] [Related]
50. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
51. In vivo tumor co-transfection with superantigen and CD80 induces systemic immunity without tolerance and prolongs survival in mice with hepatocellular carcinoma.
Li ZS; Yang XW; Chen Z; Dong HL; Ye J; Qu P; Lu SY; Zhang XM; Sui YF
Cancer Biol Ther; 2004 Jul; 3(7):660-6. PubMed ID: 15136758
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector.
Kanai F
Mol Biotechnol; 2001 Jul; 18(3):243-50. PubMed ID: 11503518
[TBL] [Abstract][Full Text] [Related]
53. [Immunological killing effect of recombicant adenovirus vector rAD-mTERT-m4-1BBL on mouse hepatoma cell line Hepa1-6 cells co-cultured with T lymphocytes].
Xiao ZS; Ma SY; Gong WD; Yao HH; DU P; Xing YQ; Wu HR
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):894-8. PubMed ID: 20193326
[TBL] [Abstract][Full Text] [Related]
54. The EIIAPA chimeric promoter for tumor specific gene therapy of hepatoma.
Hsieh YJ; Chen FD; Ke CC; Wang HE; Huang CJ; Hou MF; Lin KP; Gelovani JG; Liu RS
Mol Imaging Biol; 2012 Aug; 14(4):452-61. PubMed ID: 21796480
[TBL] [Abstract][Full Text] [Related]
55. Construction of conditionally replicating adenovirus expressing staphylococcal enterotoxin A gene: potential usefulness for anti-tumor therapies.
Zhang PY; Hao L; Zhang ZG; Dong BZ; Yang D; Wang XL; Xuan XJ; Yan Z; Qing L; Shi ZD; Liu D; Han CH
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2258-63. PubMed ID: 25219823
[TBL] [Abstract][Full Text] [Related]
56. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus.
Ohashi M; Kanai F; Tateishi K; Taniguchi H; Marignani PA; Yoshida Y; Shiratori Y; Hamada H; Omata M
Biochem Biophys Res Commun; 2001 Mar; 282(2):529-35. PubMed ID: 11401492
[TBL] [Abstract][Full Text] [Related]
57. Local delivery of recombinant adenovirus expressing hepatitis B virus X protein and interleukin-12 results in antitumor effects via inhibition of hepatoma cell growth and intervention of tumor microenvironment.
He H; Fan P; Yin T; Chen Q; Shi H; Liu S; Li H; Jing Q; Yan Y; Zhang H; Yang L; Wen Y; Li Y; Cheng P
Int J Mol Med; 2012 Sep; 30(3):599-605. PubMed ID: 22710287
[TBL] [Abstract][Full Text] [Related]
58. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
59. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
[TBL] [Abstract][Full Text] [Related]
60. [Dendritic cell vaccine modified by murine mAFP gene enhances immunoprotective effect on liver carcinogenesis and tumor development in mice].
Xie YA; Kuang ZP; Liang AM; Luo XL; Yang F; Wu JN
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):250-4. PubMed ID: 18788625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
